Curitiba-based biotechnology company advances synthesized compounds into in vitro testing in Brazilian laboratories.
Gifford Bioscience Limited is a UK preclinical contract research organisation based at BioHub Birmingham®. Established in ...
SAN DIEGO - October 15, 2026 — Paradigm Clinical Research, Inc., a clinical research site organization, announced today the ...
AstraZeneca will tap AI-focused insitro to find new targets for metabolic dysfunction-associated steatohepatitis and ...
First clinical evaluation of Xenetic's systemic DNase technology as an adjunct to CAR T-cell therapy in an ...
Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a novel composite outcome defined by ...
A case study presented at Child Neurology Society Annual Meeting demonstrates preservation of neurological function in ...
Company Points to Four Active Tracks - Software Monetization, StrainScan Pro Outreach, Subsidiary Collectibles Flow, and ...
Arrowhead Pharmaceuticals’ siRNA candidate achieved “compelling” tau reductions in an early study of healthy volunteers, with ...
Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System
Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in ...
Platform combines document extraction, specialist linguistic review, and automated layout reconstruction to simplify adverse ...
(Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results